Exelixis (EXEL) Inventory (2013 - 2026)
Exelixis (EXEL) recorded quarterly Inventory of $26.6 million in Q2 2026, up 22.68% quarter-over-quarter from $21.7 million in Q1 2026, and up 7.05% on a YoY basis from $24.9 million in Q2 2025.
Exelixis (EXEL) Inventory (2013 - 2026) Analysis & Trends
Exelixis' Inventory history runs 14 years deep, the most recent figure standing at $26.6 million for Q2 2026.
- In Q2 2026, Inventory rose 7.05% year-over-year to $26.6 million; the TTM figure through Apr 2026 stood at $26.6 million (up 7.05% YoY), while the FY2026 annual figure was $21.7 million, down 3.14% from the prior year.
- Inventory was $26.6 million for Q2 2026 at Exelixis, up from $21.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $33.3 million in Q4 2022 to a low of $17.3 million in Q4 2023.
- Historically, Inventory has averaged $25.4 million across 5 years, with a median of $25.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Inventory soared 32.18% in 2022, then tumbled 47.98% in 2023.
- A 5-year view of Inventory shows it stood at $33.3 million in 2022, then sank by 47.98% to $17.3 million in 2023, then gained by 21.3% to $21.0 million in 2024, then surged by 30.4% to $27.4 million in 2025, then dropped by 2.91% to $26.6 million in 2026.
- The last three Inventory figures came in at $26.6 million (Q2 2026), $21.7 million (Q1 2026), and $27.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 26.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 26.61 Mn |
| Jan 2, 2026 | 21.69 Mn |
| Oct 3, 2025 | 27.40 Mn |
| Jul 4, 2025 | 23.48 Mn |
| Apr 4, 2025 | 24.85 Mn |
| Jan 3, 2025 | 22.39 Mn |
| Sep 27, 2024 | 21.01 Mn |
| Jun 28, 2024 | 20.61 Mn |
| Mar 29, 2024 | 21.11 Mn |
| Dec 29, 2023 | 17.32 Mn |
| Sep 29, 2023 | 24.98 Mn |
| Jun 30, 2023 | 28.64 Mn |
| Mar 31, 2023 | 29.91 Mn |
| Dec 30, 2022 | 33.30 Mn |
| Sep 30, 2022 | 26.71 Mn |
| Jul 1, 2022 | 33.02 Mn |
| Apr 1, 2022 | 28.47 Mn |
| Dec 31, 2021 | 27.49 Mn |
| Oct 1, 2021 | 28.24 Mn |
| Jul 2, 2021 | 24.98 Mn |